GUD — Knight Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$586.75m
- CA$473.08m
- CA$371.30m
- 96
- 42
- 70
- 80
Annual cashflow statement for Knight Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 31.8 | 15.7 | -29.9 | -16.8 | 4.33 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -50.5 | -9.33 | 37.9 | 38.4 | 1.71 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.6 | -2.01 | -8.49 | -26.9 | -19.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.2 | 44.6 | 45 | 35.9 | 36.3 |
| Capital Expenditures | -20.7 | -224 | -25.8 | -9.96 | -31.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 122 | 119 | -37.3 | 39.3 | 48.4 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 101 | -105 | -63.1 | 29.3 | 17 |
| Financing Cash Flow Items | 0.231 | 0.297 | -4.18 | -9.5 | -7.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -29.2 | -78.3 | -2.76 | -81 | -33.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 55.3 | -144 | -14.3 | -12.9 | 21.3 |